Status:

COMPLETED

A Study of Clinical Outcomes of the REALIZE Adjustable Gastric Band-C

Lead Sponsor:

Ethicon Endo-Surgery

Conditions:

Morbid Obesity

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to evaluate the results patients are obtaining with the Realize™ Adjustable Gastric Band-C during the first 24 months after surgery.

Eligibility Criteria

Inclusion

  • Received an implant with the Realize Band-C according to the following indications for use:
  • Body Mass Index (BMI) of at least 40 kg/m2, or a BMI of at least 35 kg/m2 with one or more co-morbid conditions.
  • Male and female adult patients (adult is defined as 18 years of age or older)
  • Failed more conservative weight-reduction alternatives, such as supervised diet, exercise, and behavior modification programs.
  • Able to comprehend, follow, and give signed informed consent.

Exclusion

  • Inflammatory diseases of the gastrointestinal tract, including severe intractable esophagitis, gastric ulceration or duodenal ulceration, or specific inflammation such as Crohn's disease;
  • Severe cardiopulmonary disease or other serious organic disease;
  • Upper gastrointestinal bleeding conditions such as esophageal or gastric varices or intestinal telangiectases;
  • Portal hypertension;
  • Anomalies of the gastrointestinal tract such as atresia or stenosis;
  • Cirrhosis of the liver;
  • Chronic pancreatitis;
  • Localized or systemic infection;
  • On chronic, long-term systemic steroid treatment or systemic steroids within 15 days of surgery;
  • Unable or unwilling to comply with dietary restrictions required by this procedure;
  • Known allergy to materials contained in the gastric band or its Injection Port;
  • Women who are pregnant;
  • Women at childbearing potential planning to get pregnant within 2 years or not using acceptable methods of contraception.

Key Trial Info

Start Date :

November 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2012

Estimated Enrollment :

231 Patients enrolled

Trial Details

Trial ID

NCT00999661

Start Date

November 1 2009

End Date

May 1 2012

Last Update

February 7 2014

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Los Angeles, California, United States

2

Celebration, Florida, United States

3

Joliet, Illinois, United States

4

Holland, Michigan, United States